Kevin James Craig - 25 Jun 2026 Form 4 Insider Report for AtaiBeckley Inc. (ATAI)

Reporting relationship: Chief Medical Officer
Issuer ticker: ATAI
Reported as of: 25 Jun 2026
Net transaction value: -$192,031
SEC form: 4
Accepted by SEC: 29 Jun 2026, 18:00:39 UTC
Prior SEC filing: 22 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Ryan Barrett, as attorney in fact

Key filing fact

Kevin James Craig filed Form 4 for AtaiBeckley Inc. (ATAI) on 29 Jun 2026.

Key facts

This page summarizes Kevin James Craig's Form 4 filing for AtaiBeckley Inc. (ATAI).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 29 Jun 2026, 18:00.

Change

Previous filing in this sequence was filed on 22 Apr 2026.
Current net transaction value: -$192,031.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002049601 Primary reporting owner

Craig Kevin James

Relationship: Chief Medical Officer
Address: C/O ATAI LIFE SCIENCES US, INC., C/O INDUSTRIOUS NYC, 250 WEST 34TH ST., NEW YORK
Signature: /s/ Ryan Barrett, as attorney in fact
Signature date: 29 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATAI transaction

Common Stock

Options Exercise

Transaction value
Shares: +33,051
Change %: +392%
Price: $1.50^*
Shares after: 41,488
Date: 25 Jun 2026
Ownership: Direct
Footnotes: F1

ATAI transaction

Common Stock

Options Exercise

Transaction value
Shares: +9,528
Change %: +23%
Price: $1.18^*
Shares after: 51,016
Date: 25 Jun 2026
Ownership: Direct
Footnotes: F1

ATAI transaction

Common Stock

Sale

Transaction value: $192,031
Shares: -42,579
Change %: -83%
Price: $4.51
Shares after: 8,437
Date: 25 Jun 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATAI transaction Derivative

Stock Option

Options Exercise

Transaction value
Shares: -33,051
Change %: -4.7%
Price: $0.000000^*
Shares after: 673,808
Date: 25 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 33,051
Exercise price: $1.50
Footnotes: F1, F3

ATAI transaction Derivative

Stock Option

Options Exercise

Transaction value
Shares: -9,528
Change %: -25%
Price: $0.000000^*
Shares after: 28,608
Date: 25 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,528
Exercise price: $1.18
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.

Footnote F2

The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $4.50 to $4.54. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price

Footnote F3

The stock option vested as to 25% of the underlying shares on January 1, 2026, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter.

Footnote F4

The stock option vested as to 25% of the underlying shares on March 14, 2024, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter.